Reduced Inflammatory Hyperalgesia with Preservation of Acute Thermal Nociception in Mice Lacking Cgmp-Dependent Protein Kinase I
Total Page:16
File Type:pdf, Size:1020Kb
Reduced inflammatory hyperalgesia with preservation of acute thermal nociception in mice lacking cGMP-dependent protein kinase I Irmgard Tegeder*†, Domenico Del Turco‡, Achim Schmidtko*, Matthias Sausbier§, Robert Feil¶, Franz Hofmann¶, Thomas Deller‡, Peter Ruth§, and Gerd Geisslinger* *pharmazentrum frankfurt and ‡Institut fu¨r Klinische Neuroanatomie, Klinikum der Johann Wolfgang Goethe-Universita¨t, 60590 Frankfurt am Main, Germany; §Pharmakologie und Toxikologie, Pharmazeutisches Institut, Universita¨t Tu¨ bingen, 72076 Tu¨bingen, Germany; and ¶Institut fu¨r Pharmakologie und Toxikologie der Technischen Universita¨t, 80802 Munich, Germany Edited by Joseph A. Beavo, University of Washington School of Medicine, Seattle, WA, and approved December 18, 2003 (received for review July 1, 2003) cGMP-dependent protein kinase I (PKG-I) has been suggested to tion on the PNAS web site.) Hence, the exact role of PKG-I in contribute to the facilitation of nociceptive transmission in the nociception remains elusive. spinal cord presumably by acting as a downstream target of nitric In the present study we used PKG-IϪ/Ϫ mice to clearly assess oxide. However, PKG-I activators caused conflicting effects on the role of PKG-I in nociception. Because these mice have a nociceptive behavior. In the present study we used PKG-I؊/؊ mice defective regulation of smooth muscle contraction with vascular to further assess the role of PKG-I in nociception. PKG-I deficiency and intestinal dysfunctions (17, 18), the overall constitution of Ϫ Ϫ was associated with reduced nociceptive behavior in the formalin homozygous PKG-I / mice deteriorates between 5 and 6 weeks assay and zymosan-induced paw inflammation. However, acute of age (17). We therefore used 3- to 4-week-old animals for thermal nociception in the hot-plate test was unaltered. After nociceptive experiments in the present study. spinal delivery of the PKG inhibitor, Rp-8-Br-cGMPS, nociceptive behavior of PKG-I؉/؉ mice was indistinguishable from that of Materials and Methods PKG-I؊/؊ mice. On the other hand, the PKG activator, 8-Br-cGMP Animals. The generation of the PKG-I null allele and genotyping (250 nmol intrathecally) caused mechanical allodynia only in PKG- was done as described (17). Mice were bred and maintained in -I؉/؉ mice, indicating that the presence of PKG-I was essential for the animal facility of the Institut fu¨r Pharmakologie und Tox this effect. Immunofluorescence studies of the spinal cord revealed ikologie der Technischen Universita¨t Munich. For nociceptive Ϫ/Ϫ ϩ/ϩ additional morphological differences. In the dorsal horn of 3- to testing PKG-I and litter-matched PKG-I mice were 4-week-old PKG-I؊/؊ mice laminae I–III were smaller and contained shipped to the Institut fu¨r Klinische Pharmakologie, Klinikum fewer neurons than controls. Furthermore, the density of sub- der Johann Wolfgang Goethe-Universita¨t Frankfurt. Experi- stance P-positive neurons and fibers was significantly reduced. The ments were performed the day after the arrival. Mice had free access to food and water before and during the experiments. The paucity of substance P in laminae I–III may contribute to the Ϯ ؊/؊ mean SD total body mass of wild-type and knockout mice was reduction of nociception in PKG-I mice and suggests a role of Ϯ Ϯ PKG-I in substance P synthesis. 16.2 2.7 g and 14.2 2.8 g, respectively (12.5% difference). The lean body mass differs by Ϸ8%. All experiments were approved by the local Ethics Committee for Animal Research spinal cord ͉ substance P ͉ nitric oxide ͉ pain and conformed to IASP ethical guidelines. he second messenger cGMP is formed by activation of Nociceptive Testing. Formalin assay. Fifteen microliters of a 5% Tsoluble and particulate guanylyl cyclases and has several formaldehyde solution was injected into the s.c. space at the targets, including cGMP-dependent protein kinase I (PKG-I) dorsal side of the right hind paw. The time spent licking the and PKG-II, of which PKG-I is expressed in the spinal cord (1, formalin-injected paw was recorded in 5-min intervals up to 45 2). Spinally delivered PKG inhibitors reduce formalin-induced min, starting right after formalin injection. The PKG-I inhibitor nociceptive behavior in rats (3, 4), suggesting that PKG-I plays Rp-8-Br-cGMPS (Biolog Life Sciences Institute, Bremen, Ger- an important role in spinal nociceptive processing. It has been many) was delivered onto the lumbar spinal cord by intrathecal speculated that PKG-I mediates hyperalgesic effects of nitric injection as has been described (19). The drug was dissolved in ϩ ϩ oxide (NO) (5). This idea is supported by the observation that artificial cerebrospinal fluid (141.7 mM Na ͞2.6 mM K ͞0.9 2ϩ͞ 2ϩ͞ Ϫ͞ Ϫ͞ PKG-I inhibition causes a reduction of thermal hyperalgesia mM Mg 1.3 mM Ca 122.7 mM Cl 21.0 mM HCO3 2.5 2Ϫ͞ induced by injection of the NO donor, NOC-12 (6). Endogenous mM HPO4 3.5 mM dextrose, bubbled with 5% CO2 in 95% O2 NO is produced by NO synthases, of which neuronal nitric oxide to adjust the pH to 7.2) and injected in a volume of 5 l. The dose synthase (nNOS) is activated and up-regulated after N-methyl- (50 nmol) was 1͞10th of the dose previously found to reduce D-aspartate receptor stimulation (7–10). NO probably acts as a flinching behavior in rats (4, 15). Drug injection was performed retrograde messenger (11, 12) at nociceptive synapses, i.e., it is in short isoflurane anesthesia 10 min before the injection of released from the postsynaptic neuron, diffuses back to the formalin. presynaptic neuron, and stimulates guanylyl cyclases. The latter Mechanical hyperalgesia in zymosan-induced paw inflammation. Mice step links NO to cGMP production and PKG-I activation. were adapted to the test perspex chamber with a grid bottom for PHARMACOLOGY Because inhibition of NOS activity reduces nociception (13, 14), the release of NO is thought to contribute to the development This paper was submitted directly (Track II) to the PNAS office. of hyperexcitability of nociceptive neurons under certain cir- Abbreviation: MPWT, mechanical paw-withdrawal threshold; PKG, cGMP-dependent pro- cumstances. Under the premise that PKG-I is a mediator of NO tein kinase; LTP, long-term potentiation; nNOS, neuronal nitric oxide synthase. at nociceptive synapses, one would expect that PKG-I activation †To whom correspondence should be sent at the present address: NPRG, Department of also causes hyperalgesia. However, effects of the spinally deliv- Anesthesia, Massachusetts General Hospital and Harvard Medical School, 149 13th Street, ered PKG activator 8-Br-cGMP have been conflicting (15, 16). Room 4309, Charlestown, MA 02129. E-mail: [email protected]. (See Supporting Text, which is published as supporting informa- © 2004 by The National Academy of Sciences of the USA www.pnas.org͞cgi͞doi͞10.1073͞pnas.0304076101 PNAS ͉ March 2, 2004 ͉ vol. 101 ͉ no. 9 ͉ 3253–3257 Downloaded by guest on September 25, 2021 at least 30 min before baseline testing. Fifteen microliters of a 10 tions, 1 m) were obtained by using a Zeiss LSM 510 confocal mg͞ml zymosan (Sigma) suspension in PBS (0.1 M PBS, pH 7.4) laser-scanning microscope. was then injected into the plantar side of the right hind paw. Mechanical hyperalgesia was assessed before zymosan injection Image Analysis. For quantitative analysis of cell and fiber densi- and then hourly up to7hafterzymosan injection. The threshold ties, midlumbar spinal cord sections (L4͞5) from PKG-IϪ/Ϫ mice to mechanical nociceptive stimuli was assessed by means of a (n ϭ 3) and PKG-Iϩ/ϩ mice (n ϭ 3) were used. Quantification punctuated stimulation by using von Frey hairs of different was performed as described (21), with modifications. Sections strengths (0.008, 0.02, 0.04, 0.07, 0.16, 0.4, 0.6, 1, 1.4, 2, 4, and 6 g; stained for substance P and NeuN and sections stained for nNOS Stoelting). They were placed perpendicularly onto the plantar and NeuN were analyzed (n ϭ 5 per animal per staining). surface of the right or left paw and bent slightly to apply Confocal images were captured by using identical settings for all punctuated pressure. The stimuli were applied at five repetitions sections. Images were analyzed with IMAGEJ 1.31 (http:͞͞ each and at increasing order until the paw was withdrawn and rsb.info.nih.gov͞ij). NeuN labeling of neurons was used to then at decreasing order until paw withdrawal stopped. This identify lamina I–III of the dorsal horn. Cell numbers, mean up-and-down testing was repeated after a short rest. The geo- pixel values, and areas of laminae I–III were determined and metric mean of uppermost (increasing testing) and lowest compared by using Student’s t test (SPSS 11.0). Values of P Ͻ 0.05 (decreasing testing) test results was taken as the mechanical were considered as statistically significant. paw-withdrawal threshold (MPWT). These data were log- transformed, and the percent decrease of the withdrawal thresh- Results old was then calculated in relation to the baseline withdrawal Formalin Assay. PKG-IϪ/Ϫ mice spent significantly less time threshold as: % decrease of MPWT ϭ MPWTbaseline Ϫ licking the formalin-injected hind paw than PKG-Iϩ/ϩ mice (Fig. MPWTzymosan͞MPWTbaseline⅐100. 1). These differences occurred in the first and second phase of Mechanical allodynia induced by 8-Br-cGMP. After two baseline mea- the formalin assay. Injection of the PKG inhibitor Rp-8-Br- surements 250 nmol of 8-Br-cGMP was injected into the sub- cGMPS significantly reduced the licking behavior in PKG-Iϩ/ϩ arachnoid space of the lumbar spinal cord in 5 l of artificial mice but had no effect in PKG-IϪ/Ϫ mice.